Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer

Pathology Oncology Research : POR
Laszló ZoltanSzabolcs Bellyei

Abstract

The aim of the present study was to investigate the relationship between the intensity of biomarker expression and the response to radiochemotherapy in patients with advanced esophageal squamous cell cancer (ESCC). Ninety-two patients with locally advanced ESCC were examined retrospectively. Pre-treatment tumor samples were stained for proteins SOUL, Hsp 16.2, Growth Hormone-Releasing Hormone Receptor (GHRH-R) and p-Akt using immunhistochemistry methods. Kaplan-Meier curves were used to show the relationship between intensity of expression of biomarkers and clinical parameters and 3-year OS. A significant correlation was found between high intensity staining for Hsp 16.2, p-Akt and SOUL and poor response to NRCT. Application of a higher dose of radiation and higher dose of cisplatin resulted in better clinical and histopathological responses, respectively. Among the clinical parameters, the localization of the tumor in the upper-third of the esophagus and less than 10% weight loss were independent prognostic factors for increased 3-year OS. Hsp16.2, p-Akt and SOUL are predictors of negative response to NRCT, therefore these biomarkers may become promising targets for therapy. Furthermore, level of expression of p-Akt, weight lo...Continue Reading

References

Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·G HalmosT Czompoly
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z RekasiG Halmos
Oct 9, 2003·Alimentary Pharmacology & Therapeutics·M R B Keighley
Oct 22, 2004·The New England Journal of Medicine·Rolf SauerUNKNOWN German Rectal Cancer Study Group
Feb 12, 2005·Antioxidants & Redox Signaling·Arnaud ParcellierCarmen Garrido
Mar 21, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J Ian GehRobert Glynne-Jones
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre GérardLaurent Bedenne
Dec 1, 2006·Apoptosis : an International Journal on Programmed Cell Death·Szabolcs BellyeiFerenc Gallyas
Feb 6, 2007·European Journal of Cell Biology·Szabolcs BellyeiFerenc Gallyas
Mar 3, 2007·The Lancet Oncology·Val GebskiUNKNOWN Australasian Gastro-Intestinal Trials Group
Jun 2, 2007·The Lancet Oncology·Christophe MarietteJean-Pierre Triboulet
Aug 25, 2007·World Journal of Surgical Oncology·Charles M GillhamDonal Hollywood
Sep 18, 2009·Pathology Oncology Research : POR·Andras PappOrs Peter Horvath
May 17, 2013·Expert Opinion on Pharmacotherapy·Masanobu Nakajima, Hiroyuki Kato
Apr 22, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lin XueJie Ding
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Sep 5, 2015·Journal of Experimental & Clinical Cancer Research : CR·Zhengfei ZhuKuaile Zhao
Apr 30, 2016·Acta Biochimica Et Biophysica Sinica·Xiaoxia WangBinquan Wang
Sep 8, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·YiRong XuXiongFeng Li

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Software Mentioned

SPSS
SOUL
Statistical Package for the Social Sciences software ( SPSS

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.